Live Breaking News & Updates on Abecma

Stay updated with breaking news from Abecma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Ide-Cel for Triple-Class Exposed R/R Multiple Myeloma

The FDA has approved ide-cel (Abecma) for adult patients with relapsed or refractory multiple myeloma after two or more prior lines of therapy. ....

Bristol Myers Squibb , Bryan Campbell , International Staging System , Cell Therapy , Eligibility Criteria , Revised International Staging System , Multiple Myeloma , Ide Cel , Cart Cell Therapy ,

Immune Engager Therapies Demonstrate Promise Following Relapse on Ide-Cel in Multiple Myeloma

Treatment with immune engager therapies following relapse on ide-cel resulted in better median PFS vs other therapies for patients with multiple myeloma. ....

Murali Janakiram , Cellular Therapy Meetings , 2024 Transplantation Amp Cellular Therapy Meetings , Immune Engager Therapies , Progression Free Survival , Multiple Myeloma , Idecabtagene Vicleucel , Ide Cel ,

Idecabtagene Vicleucel Approaches EU Approval in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

The EMA's CHMP has recommended the approval of idecabtagene vicleucel in patients with multiple myeloma who received at least 2 prior therapies. ....

Anne Kerber , International Staging System , Oncologic Drugs Advisory Committee , Late Clinical Development , European Commission , Bristol Myers Squibb , European Medicines Agency , Medicinal Products , Human Use , Cell Therapy , Revised International Staging System , Drugs Advisory Committee , Myers Squibb , Idecabtagene Vicleucel , Ide Cel , Multiple Myeloma , Committee For Medicinal Products Human Use , Karmma 3 Study , Cart Cell Therapy , Car T , Immunomodulatory Drug , Proteasome Inhibitor , Anti Cd38 Monoclonal Antibody ,

Ecma: 'Four to five years is the required development period for BS VII', ET Auto

In the global trend of increasingly stringent emission norms, Euro 7, proposed for enforcement in light duty vehicles from July 2025, will set a new record. India has been following Europe for its emission regulations. In this exclusive interview, President, ECMA (an industry Body exclusively for emission control technology suppliers in India), and Head – Commercial, BASF Catalysts India, Harindranath Revanur, discusses with ETAuto’s Sumantra Bibhuti Barooah about BSVII, how easy or challenging the shift could be, and the growing scope of ECMA. ....

Harindranath Revanur , Etauto Sumantra Bibhuti Barooah , Sumantra Bibhuti Barooah , Harindranath Revanur ,

Ethiopia opens up more sectors as exchange readies for launch

Ethiopia has in the last two years opened up its telecommunications and banking sectors to participation of foreign firms. ....

International Finance Corporation , Ethiopia Securities Exchange , Ethiopian Capital Markets Authority , Africa Financial Industry Summit , Ethiopia Foreign Investments , Thiopia Securities Exchange , Aliou Maiga , Brook Taye ,